Knoxville, TN, April 7, 2014: Imelda G. Margulies, MSN, FNP-BC, Coordinator for the High Risk Assessment Clinic at the Knoxville Comprehensive Breast Center, has been selected one of the few cancer risk genetic counselors in the country by Myriad Genetic Laboratories, Inc. to offer patients the Myriad myRisk™ Hereditary Cancer Panel that offers more than just BRCA testing. Myriad myRisk™ Hereditary Cancer Panel represents a new paradigm for clinical genetic testing for inherited cancer risk. The previous model was based on the analysis of one or a small number of genes for individual syndromes, with the choice based on consideration of the patient’s personal and family history. The new model encompasses the simultaneous analysis of a larger number of genes combined in a panel to broadly target specific cancer sites. myRisk is a 25-gene panel for the identification of clinically significant mutations impacting inherited risks for eight important cancers: breast, colorectal, ovarian, endometrial, gastric, pancreatic, melanoma and prostate.
Imelda G. Margulies, MSN, FNP-BC, Family Nurse Practitioner, received advanced training in hereditary cancer risk assessment and cancer prevention at the City of Hope in Duarte, CA, having graduated from the Intensive Course in Cancer Risk Assessment in 2010. Mrs. Margulies is one of only two practitioners in the state of Tennessee to have graduated from the course.
myRisk offers patients a clear insight into their personalized risk of developing cancer and will provide those patients with clear direction of risk reduction based on recommendations from the National Comprehensive Cancer Network guidelines.
Imelda G. Margulies, MSN, FNP-BC, is available for consultation to see if Myriad myRisk™ Hereditary Cancer Panel is the right test for you and your family. Please call 865-583-2922 to schedule an appointment.
For more information, please contact Imelda G. Margulies at 865-583-2922.